Other combinations of entero-pancreatic hormones, including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA), have progressed to phase 3 trials as obesity treatments, and early data suggest that they may lead to even greater weight loss than tirzepatide [28]
I still enjoy an occasional drink at social events
This naturally reduces portion sizes, cravings and mindless eating, encouraging more intentional food choices
Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
Step 4: Dissolve gently Remove the needle
Maternal insulin resistance, obesity and lipid levels also contribute, and it may be more of a challenge to be able to demonstrate that CGM will improve outcomes